Amylyx Pharmaceuticals Ownership | Who Owns Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals Ownership Summary
Amylyx Pharmaceuticals is owned by 118.94% institutional investors, 6.77% insiders. Fmr is the largest institutional shareholder, holding 17.94% of AMLX shares. Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund, with 3.03% of its assets in Amylyx Pharmaceuticals shares.
AMLX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Amylyx Pharmaceuticals | 118.94% | 6.77% | -25.71% |
| Sector | Healthcare Stocks | 129.40% | 12.08% | -41.48% |
| Industry | Biotech Stocks | 181.71% | 11.69% | -93.40% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 19.95M | 17.94% | $580.41M |
| Blackrock funding, inc. /de | 10.37M | 9.32% | $301.71M |
| Perceptive advisors | 8.33M | 7.54% | $149.69M |
| Vanguard group | 5.80M | 6.22% | $70.12M |
| Tcg crossover management | 6.24M | 5.65% | $112.14M |
| Janus henderson group | 4.99M | 5.27% | $69.26M |
| Commodore capital lp | 5.65M | 5.11% | $101.47M |
| Vanguard capital management | 5.08M | 4.57% | $147.76M |
| Saturn v capital management | 4.62M | 4.18% | $83.05M |
| Blackrock | 2.67M | 3.93% | $5.07M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Saturn v capital management | 4.62M | 11.91% | $83.05M |
| Allostery investments lp | 120.12K | 9.81% | $769.96K |
| Commodore capital lp | 5.65M | 6.04% | $101.47M |
| Almitas capital | 974.88K | 4.20% | $17.51M |
| Aldebaran capital | 196.03K | 4.10% | $5.70M |
| Ally bridge group (ny) | 437.39K | 3.62% | $5.94M |
| First light asset management | 3.02M | 3.30% | $54.30M |
| Tcg crossover management | 6.24M | 2.70% | $112.14M |
| Great point partners | 700.00K | 2.38% | $12.57M |
| Perceptive advisors | 8.33M | 2.25% | $149.69M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 19.95M | 0.03% | 3.22M |
| Paradigm biocapital advisors lp | 1.90M | 0.73% | 1.90M |
| Jpmorgan chase | 3.43M | 0.01% | 1.57M |
| Blackrock funding, inc. /de | 10.37M | 0.00% | 1.54M |
| Alyeska investment group | 1.05M | 0.05% | 1.05M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 2.67M | 0.00% | -1.80M |
| Adage capital partners gp | 1.90M | 0.05% | -1.66M |
| Boxer capital | - | - | -1.50M |
| Eventide asset management | - | - | -1.33M |
| Farallon capital management | - | - | -1.15M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Paradigm biocapital advisors lp | 1.90M | 0.73% | 1.90M | $25.82M |
| Alyeska investment group | 1.05M | 0.05% | 1.05M | $18.91M |
| Braidwell lp | 612.84K | 0.25% | 612.84K | $8.33M |
| Ally bridge group (ny) | 437.39K | 3.62% | 437.39K | $5.94M |
| Nearwater capital markets | 425.00K | 0.13% | 425.00K | $7.63M |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -1.00 |
| Ameritas advisory services | -3.00 |
| Nelson, van denburg & campbell wealth management group | -10.00 |
| Financial consulate | -25.00 |
| Kelly financial services | -33.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 243 | 8.97% | 132,251,990 | 14.29% | 118 | 1.09% | 173 | 40.65% | 45 | -27.42% |
| Jun 30, 2026 | 220 | 21.55% | 115,598,683 | 1.27% | 104 | 0.98% | 123 | 35.16% | 59 | 9.26% |
| Mar 31, 2026 | 67 | -64.74% | 11,342,671 | -89.90% | 11 | 0.08% | 27 | -75.23% | 25 | -46.81% |
| Dec 31, 2025 | 114 | -35.23% | 37,817,895 | -65.53% | 40 | 0.27% | 65 | -38.10% | 25 | -46.81% |
| Sep 30, 2025 | 170 | 34.92% | 109,563,434 | 39.61% | 122 | 1.59% | 101 | 46.38% | 46 | 43.75% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 3.80M | 3.03% | 12.11K |
| Vanguard Total Stock Mkt Idx Inv | 3.15M | 2.84% | 36.90K |
| Vanguard Morn Total Stk Mkt Idx Investor | 3.15M | 2.84% | 36.90K |
| iShares Russell 2000 ETF | 2.63M | 2.05% | - |
| Fidelity Advisor Biotechnology I | 2.43M | 1.89% | - |
| Fidelity Small Cap Growth | 2.12M | 1.65% | - |
| Franklin Biotechnology Discv A(acc)USD | 1.72M | 1.37% | - |
| Strategic Advisers Fidelity US TtlStk | 1.70M | 1.32% | 384.65K |
| Fidelity Select Health Care | 1.60M | 1.27% | 180.00K |
| Fidelity Select Biotechnology | 1.47M | 1.17% | 372.94K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 09, 2026 | FRATES JAMES M | Chief Financial Officer | Sell | $370.36K |
| Nov 09, 2026 | FRATES JAMES M | Chief Financial Officer | Sell | $226.29K |
| Nov 10, 2026 | FRATES JAMES M | Chief Financial Officer | Sell | $222.98K |
| Nov 10, 2026 | FRATES JAMES M | Chief Financial Officer | Sell | $388.11K |
| Nov 09, 2026 | Klee Justin B. | Co-Chief Executive Officer | Sell | $1.10M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | - | 9 |
| 2026 Q3 | - | 12 |
| 2026 Q2 | 1 | - |
| 2026 Q1 | - | 17 |
| 2025 Q4 | 1 | 1 |
AMLX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools